Skin Patch Drug Infusion Device
Summary
The European Patent Office published patent application EP4274633A1 for Medtrum Technologies Inc., covering a skin patch drug infusion device. The invention relates to A61M medical device technology for transdermal drug delivery. Patent grants exclusive rights across 38 designated European states.
What changed
The EPO published international patent application EP4274633A1 filed by Medtrum Technologies Inc., covering a skin patch drug infusion device. The invention, invented by Cuijun Yang, is classified under A61M medical device categories including A61M 5/14, A61M 5/142, A61B 5/145, and A61B 5/00. The patent provides intellectual property protection in 38 designated European states including Germany, France, the United Kingdom, Italy, Spain, and other EU/EEA members.
Patent holders and applicants seeking to develop similar transdermal drug delivery technology in Europe should verify freedom-to-operate status and consider licensing arrangements with Medtrum Technologies Inc. No immediate compliance actions are required for existing medical device manufacturers unless their products potentially infringe this newly published patent rights.
Source document (simplified)
SKIN PATCH DRUG INFUSION DEVICE
Publication EP4274633A1 Kind: A1 Mar 25, 2026
Applicants
Medtrum Technologies Inc.
Inventors
YANG, Cuijun
IPC Classifications
A61M 5/14 20060101AFI20241105BHEP A61B 5/145 20060101ALI20241105BHEP A61B 5/00 20060101ALI20241105BHEP A61M 5/142 20060101ALI20241105BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Source
Classification
Who this affects
Taxonomy
Browse Categories
Get Healthcare alerts
Weekly digest. AI-summarized, no noise.
Free. Unsubscribe anytime.
Get alerts for this source
We'll email you when ChangeBridge: EPO Bulletin - Medical Devices (A61M) publishes new changes.